🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› France
Clinical trial register · France

Studies with a French investigative site

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9693 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:56 UTC
9693
Studies in scope
all four open statuses
6031
Recruiting now
open to new participants
1035
Lead sponsors
across recruiting studies
Top sites
Paris 2816 Lyon 1391 Bordeaux 1387 Marseille 1292 Lille 1277
Narrow the register
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris821 Hospices Civils de Lyon383 University Hospital, Strasbourg, France222 Centre Hospitalier Universitaire de Nice197 Centre Hospitalier Universitaire, Amiens192
Site location
Paris2816 Lyon1391 Bordeaux1387 Marseille1292 Lille1277
All 799 locations
Target enrolment
to

Trials in this register

9693 of 9693 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment: a French Prospective Register
NCT06642168Sudden Cardiac Arrest, Sudden Cardiac Death
Rennes University Hospital
Observational
80
Nîmes, Paris, Rennes, Bordeaux, Brest, Caen, Clermont-Ferrand, Créteil
2024-10-11
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
NCT06581432Solid Tumours
DrugZongertinib
Boehringer Ingelheim
Phase 2
588
Bordeaux, Dijon, Lyon, Marseille, Poitiers, Villejuif
2024-10-11
Recruiting
Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins
NCT06481878Alzheimer Disease
University Hospital, Grenoble
Observational
115
Grenoble
2024-10-11
Recruiting
Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air
NCT06614101Type 2 Diabetes
University Hospital, Toulouse
Not applicable
235
Salies-du-Salat, Toulouse
2024-10-11
Recruiting
Medical Comorbidities in Bipolar Disorder
NCT06872398Psychiatric Disorder
Fondation FondaMental
Observational
80
Créteil
2024-10-11
Recruiting
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
NCT06446882HER2-positive Breast Cancer, Early-stage Breast Cancer
Fundacio Clinic Barcelona
Not applicable
304
Avignon, Bordeaux, Léon, Marseille, Nancy, Paris, Toulouse
2024-10-11
Recruiting
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
NCT06609668Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)
DrugAdditional blood samples
Centre Hospitalier Universitaire Dijon
Observational
78
Dijon
2024-10-10
Active, closed
Comparison of the Flexibility of the Perineum in Primiparous Women Using the Medical Device Emagina During 90 Days of Their Pregnancy Compared to Those Having a Standard Pregnancy Follow-up
NCT06542744Pregnancy, Childbirth
Mumming
Not applicable
88
Boulogne-Billancourt, Coutances, Grandchamps-des-Fontaines, Marseille, Montpellier, Paris, Ronchin, Rouen
2024-10-10
Recruiting
Confirming And Notifying Death
NCT06910176Death Records
University Hospital, Strasbourg, France
Observational
20
Strasbourg
2024-10-10
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
NCT06598943Ulcerative Colitis, Ulcerative Colitis Chronic
DrugsEltrekibart·Mirikizumab
Eli Lilly and Company
Phase 2
143
Créteil, Grenoble, La Roche-sur-Yon, Nice, Pierre-Bénite, Rouen
2024-10-10
Active, closed
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
NCT06516952Prurigo Nodularis
DrugPovorcitinib
Incyte Corporation
Phase 3
349
Antony, Brest, Martigues, Mulhouse, Nantes, Paris, Romans-sur-Isère, Toulouse
2024-10-10
Recruiting
Body Composition and Acute Stroke
NCT06589297Acute Stroke
Centre Hospitalier Régional d'Orléans
Not applicable
250
Orléans
2024-10-10
Active, closed
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
NCT06625060Episodic Migraine, Chronic Migraine
DrugCorabotase
Ipsen
Phase 2
670
Amiens, Clermont-Ferrand, Nantes, Nîmes, Paris
2024-10-10
Recruiting
The Effect of Pulse Field Ablation on Atrial Mechanics in Catheter Ablation of Paroxysmal Atrial Fibrillation
NCT06557876Atrial Fibrillation Paroxysmal
Assistance Publique - Hôpitaux de Paris
Not applicable
80
Paris
2024-10-09
Recruiting
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
NCT06525636X-linked Hypophosphatemia
Kyowa Kirin Co., Ltd.
Phase 1/2
39
Le Kremlin-Bicêtre
2024-10-09
Active, closed
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
NCT05417789TGCT
DrugEmactuzumab
SynOx Therapeutics Limited
Phase 3
128
Bordeaux, Saint-Herblain, Paris, Lyon, Lille, Toulouse
2024-10-09
Active, closed
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
NCT06630286HIV-1-infection
DrugsISL/LEN·B/F/TAF
Gilead Sciences
Phase 3
609
Bourdeaux, Le Kremlin-Bicêtre, Marseile, Nice
2024-10-09
Recruiting
3D Ultrasound Myocardial Mechanical Wave Measurements
NCT06648577Chronic Primary Mitral Regurgitation
Assistance Publique - Hôpitaux de Paris
Observational
40
Paris
2024-10-09
Recruiting
Tourniquet Use in Hallux Valgus Surgery
NCT06680518Hallux Valgus
Clinique Saint Jean, France
Not applicable
44
Saint-Jean-de-Védas
2024-10-09
Recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
NCT06470048Diffuse Cutaneous Systemic Sclerosis
DrugIanalumab
Novartis Pharmaceuticals
Phase 2
200
Dijon, Le Mans, Lille, Montpellier, Paris, Rennes, Strasbourg, Toulouse
2024-10-09
Recruiting
Support Pathway for ENT Cancer Patients in a Support Care Day Hospital
NCT06512662Otorhinolaryngologic Neoplasms
Clinique Pasteur Lanroze
Not applicable
60
Brest
2024-10-08
Recruiting
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
NCT07277361Fabry Disease, Aged 65 Years or Older, Alpha Galactosidase A Deficiency, Galactosidase A Gene Mutation
Wladimir MAUHIN, Dr
Observational
100
Paris
2024-10-08
Recruiting
BIOmarkers Before and After Kidney Transplantation
NCT06810258Kidney Disease, Kidney Transplantation
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Créteil
2024-10-08
Recruiting
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer
NCT06600802Castration-resistant Metastatic Prostate Cancer, Treated by 177Lutetium-PSMA-617 (Lu-PSMA)
DrugBlood samples
Centre Jean Perrin
Not applicable
120
Clermont-Ferrand, La Tronche, Pierre-Bénite, Saint-Etienne, Strasbourg
2024-10-08
Recruiting
Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants
NCT06636955Acute Bronchiolitis
University Hospital, Rouen
Observational
900
Rouen
2024-10-07
Recruiting
Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis
NCT06034262Osteoarthritis Hand
DrugSclerFIX-IP
TBF Genie Tissulaire
Phase 2
14
Besançon, Lyon, Nantes
2024-10-07
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
NCT06561386Non-small Cell Lung Cancer
DrugsRelatlimab·Pemetrexed·Nivolumab·Cisplatin
Bristol-Myers Squibb
Phase 3
1,000
Dijon, Brest, Toulouse, Montpellier, Rennes, Vandœuvre-lès-Nancy, Lille, Le Mans
2024-10-07
Recruiting
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
NCT06276465Prostatic Cancer, Castration-Resistant
DrugDarolutamide
UNICANCER
Phase 3
336
Lorient, Mougins, Saint-Etienne, Villejuif
2024-10-07
Active, closed
Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)
NCT06513312Pre-Exposure Prophylaxis of HIV Infection
DrugsF/TDF·Emtricitabine/tenofovir disoproxil fumarate·Lenacapavir
Gilead Sciences
Phase 2
268
Bobigny, Marseille, Nice, Paris
2024-10-07
Recruiting
Evaluation of Artesunate in Infants Being Treated for Severe Malaria
NCT06555809Malaria
DrugArtesunate
Amivas Inc.
Observational
15
Paris
2024-10-06
Not yet open
Evaluate the Incidence of Junctional Rhythms Occurring During Post-procedure TAVI Hospitalization.
NCT06599008Incidence of Junctional Rhythm
University Hospital, Clermont-Ferrand
Observational
250
Clermont-Ferrand
2024-10-05
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bordeaux, Lyon, Montpellier, Nantes, Paris, Rouen
2024-10-05
Recruiting
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
NCT06527872Lupus Nephritis
GlaxoSmithKline
Observational
300
Marseille
2024-10-04
Active, closed
BIO|MASTER.CSP Study
NCT06620237Cardiac Pacing, Artificial, Cardiac Pacemaker, Artificial, Cardiac Resynchronization Therapy Devices, Bradycardia
Biotronik SE & Co. KG
Not applicable
152
Marseille, Metz, Nantes, Pessac
2024-10-04
Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06417814Metastatic Non-small Cell Lung Cancer
DrugsTagrisso·Datopotamab Deruxtecan·Osimertinib·Pemetrexed
AstraZeneca
Phase 3
744
Angers, Avignon, Bordeaux, Caen, Lille, Montpellier, Nantes, Paris
2024-10-04
Recruiting
Preoperative Blood Volume Optimization Using Transthoracic Echocardiography
NCT06639737Anesthesia, Anesthesia Complication, Anesthesia Induction, Arterial Hypotension
University Hospital, Caen
Not applicable
220
Caen
2024-10-04
Recruiting
Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients
NCT06713265Parkinson's Disease, Dysphagia, Swallowing Disorder, Freezing of Gait
Hopital La Musse
Observational
66
Saint-Sébastien-de-Morsent
2024-10-04
Recruiting
Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses
NCT06613334Schizophrenia
Centre Hospitalier St Anne
Not applicable
200
Paris
2024-10-04
Recruiting
Prospective Randomized Study Comparing the SpheriKA® (MEDACTA) and Origin® (SYMBIOS) Prostheses During Total Knee Replacement Using the Kinematic Alignment Technique
NCT06603103Knee Osteoarthritis
Clinique du Sport, Bordeaux Mérignac
Not applicable
120
Mérignac
2024-10-03
Recruiting
Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability
NCT06291038Irritable Bowel Syndrome
University Hospital, Rouen
Not applicable
60
Amiens, Caen, Le Havre, Rouen
2024-10-03
Recruiting
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
NCT05947955Acute Respiratory Distress Syndrome, Infections
BioAegis Therapeutics Inc.
Phase 2
600
La Roche-sur-Yon, Le Kremlin-Bicêtre, Melun, Nantes, Oullins-Pierre-Bénite, Paris, Strasbourg
2024-10-03
Recruiting
Transcutaneous Vagus Nerve Stimulation as a Complementary Therapy to Exercise in Chronic Fatigue
NCT06170645Chronic Fatigue Syndrome
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
60
Saint-Etienne
2024-10-03
Recruiting
A Multimodal Study of the Relationship Between Exposure to Endocrine Disruptors and Occurrence of Hypospadias - HYPOLLUT
NCT06628375Hypospadias
University Hospital, Montpellier
Observational
200
Montpellier
2024-10-03
Recruiting
The Prevalence of the Aortic to Radial Pressure Gradient in States of Shock, Outside the Context of Cardiac Surgery, a Prospective Study
NCT06460519Shock
Hospices Civils de Lyon
Observational
180
Bron, Clermont-Ferrand, Lyon
2024-10-03
Recruiting
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
NCT06559891Hypertension
SoniVie Inc.
Not applicable
261
Bordeaux, Paris
2024-10-03
Recruiting
Radiohistological Correlation of Thrombohemorrhagic Remodeling in the Acute Phase of Ischemic Stroke Managed by Decompressive Hemicraniectomy
NCT05847699Acute Ischemic Stroke
Fondation Ophtalmologique Adolphe de Rothschild
Not applicable
15
Paris
2024-10-02
Recruiting
Echocardiography in Nursing Home
NCT06445231Heart Diseases, Heart Failure, Heart Valve Diseases
Nantes University Hospital
Not applicable
1,050
Nantes
2024-10-02
Recruiting
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
NCT06490757Inflammatory Hepatocellular Adenoma
DrugBaricitinib
Assistance Publique - Hôpitaux de Paris
Phase 2
25
Bobigny
2024-10-02
Recruiting
Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace
NCT07312474Human Anaplasmosis
University Hospital, Strasbourg, France
Observational
100
Strasbourg
2024-10-02
Recruiting
European, Multi-center, Exploratory Trial to Assess WEB Versus Other Endovascular Treatment in Ruptured Aneurysms.
NCT06511245Ruptured Aneurysm
Microvention-Terumo, Inc.
Not applicable
80
Reims
2024-10-02
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy
NCT06568237Multiple System Atrophy
DrugTEV-56286
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
350
Bordeaux, Caen, Marseille, Paris, Toulouse
2024-10-02
Not yet open
The Personalized Psychological Treatment for Psychosis
NCT06603922Schizophrenia, Psychosis, Schizophrenia Spectrum and Other Psychotic Disorders
Polish Academy of Sciences
Not applicable
252
Strasbourg
2024-10-01
Recruiting
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
NCT06207383Atrial Fibrillation, Persistent, Heart Failure
University Hospital, Geneva
Not applicable
220
Rouen
2024-10-01
Recruiting
Efficacy and Safety of Dalbavancin As Suppressive Therapy
NCT06899906Efficacy and Safety of Dalbavancin, In Subjects Who Received SAT with DAL, For Acute or Chronic Infections Between July 2019 and December 2024
Hospices Civils de Lyon
Observational
33
France
2024-10-01
Recruiting
Prognostic Value of the Rockwood Clinical Frailty Score in Cardiogenic Shock
NCT06692855Cardiogenic Shock
University Hospital, Strasbourg, France
Observational
300
Strasbourg
2024-10-01
Recruiting
Functional Impairment in Albinism
NCT06345976Albinism, Ocular
Fondation Ophtalmologique Adolphe de Rothschild
Observational
50
Paris
2024-10-01
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT06510374Intermediate Risk Non-Muscle Invasive Bladder Cancer
DrugNadofaragene Firadenovec
Ferring Pharmaceuticals
Phase 3
454
Clermont-Ferrand, Toulouse, Nantes, Bordeaux, Rouen, Nîmes, Lyon, Paris
2024-10-01
Active, closed
Assessment of the Perceptions and Opinions of Staff Working of Prisons and Detention Centers on the Use of Psychoactive Substances in Prisons and Harm Reduction (PERRCEP)
NCT06894589Harm Reduction, Prisoners
University Hospital, Brest
Observational
800
Brest
2024-10-01
Active, closed
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
NCT06506955Advanced/Metastatic Cancer
DrugFutibatinib
Taiho Oncology, Inc.
Phase 2/3
15
Marseille, Strasbourg
2024-10-01
Not yet open
Intestinal Microbiota and Visceral Pain in Chronic Intestinal Pseudo-Obstruction Syndrome (CIPO)
NCT06610929Intestinal Obstruction
Assistance Publique - Hôpitaux de Paris
Observational
30
Paris
2024-10-01
Not yet open
Ability of Rotator Cuff Muscle Strength Levels, Assessed by Isokinetic Dynamometry, to Predict Return to Sport After Shoulder Stabilization Surgery by Open Latarjet Procedure
NCT06602713Latarjet, Shoulder Injuries, Rotator Cuff Injuries
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
210
Lyon
2024-10-01
Not yet open
Evaluation of Updated Procedure for Management of Refractory Out-of-hospital Cardiac Arrests
NCT06603649Cardiac Arrest, Out-Of-Hospital
Central Hospital, Nancy, France
Observational
150
Nancy
2024-10-01
Not yet open
French Prospective Cohort of Innovative Endoscopic Interventions in Expert Centers
NCT06589882Endoscopy, Innovative Procedures
Centre Hospitalier Universitaire de Nīmes
Observational
10,000
Nîmes, Paris
2024-10-01
Recruiting
Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384
NCT06623071Hepatitis B
CerbaXpert
Observational
45
Frépillon, France
2024-10-01
Not yet open
Trancriptomics and Lipidomics of Epicardial Ectopic Fat
NCT06590415Type 2 Diabetes
Assistance Publique Hopitaux De Marseille
Not applicable
84
Marseille
2024-10-01
Not yet open
Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384
NCT06623058HEPATITIS C (HCV)
CerbaXpert
Observational
45
Frépillon
2024-10-01
Not yet open
Peer Support in Alcohol Dependence
NCT06381609Alcohol Use Disorder
Hospices Civils de Lyon
Not applicable
626
Bron, Clichy, Lyon, Paris
2024-10-01
Recruiting
Registry of PHAcoemulsification for Cataract Surgery
NCT06659419Cataract
Assistance Publique - Hôpitaux de Paris
Observational
100,000
Paris
2024-10-01
Active, closed
Method for bAdge-dosi Monitoring of X-ray Exposure Values in Operating Theatre Surgery
NCT06659939X-Ray
University Hospital, Tours
Not applicable
118
Orléans, Pessac, Toulouse, Tours
2024-10-01
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
NCT06545955Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
DrugsNadofaragene Firadenovec·Docetaxel·Gemcitabine·Pembrolizumab
Ferring Pharmaceuticals
Phase 3
250
Clermont-Ferrand, Lyon, Toulouse, Nantes, Bordeaux, Nîmes, Paris
2024-10-01
Recruiting
Clozapine-related Immunodeficiency in Parkinsons Disease
NCT06634641Clozapine, Parkinson's Disease (PD), Immunodeficiency, Psychosis
DrugBlood test
Centre Hospitalier Universitaire, Amiens
Phase 4
24
Salouël
2024-10-01
Active, closed
Prevention Workshop to Address Bullying Behaviors in Schools
NCT06835205Bullying of Child, Child Behavior Disorders, Social Behavior, Mental Health
University Hospital, Grenoble
Not applicable
900
Grenoble
2024-10-01
Recruiting
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
NCT06552234NSCLC Stage IV, NSCLC, Stage III
DrugRepotrectinib
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase 2
30
Aix-en-Provence, Marseille, Toulon, Angers, Bordeaux, Brest, Caen, Chambéry
2024-10-01
By invitation
Evaluation of Interprofessional Relations Between Primary Care and Hospital Centers in the Experimentation of Medical Cannabis in France Carried Out by the ANSM (ECIPCanna)
NCT06597097Medical Cannabis
University Hospital, Brest
Observational
108
Brest
2024-10-01
Recruiting
Virtual Reality Implantation in Paediatric Rehabilitation (IMPLANT-VR4 CHILD)
NCT06627049Children with Undergoing Rehabilitation
Fondation Ildys
Observational
39
Brest, Roscoff
2024-10
Not yet open
Outcome-related Performance Evaluation Through Revision and Analysis of inTraoperative Events
NCT06655948Laparoscopic Abdominal Surgery
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
700
Strasbourg
2024-10
Not yet open
Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit
NCT05542329Care After Going to Intensive Care
University Hospital, Strasbourg, France
Not applicable
448
Dijon, Mulhouse, Nancy, Strasbourg
2024-10
Not yet open
Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm
NCT06582186Aspergillosis Invasive, Fungal Infection, Hematologic Malignancy
University Hospital, Grenoble
Phase 4
30
Grenoble
2024-10
Recruiting
Comparison of 3 RF Delivery Modes of the QDOT Catheter for Paroxymal Atrial Fibrillation (AF) Ablation
NCT06647251Atrial Fibrillation
Institut Mutualiste Montsouris
Not applicable
90
Paris
2024-10
Not yet open
Oncological Prognosis of Prostate Lesions by Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (CEST-MRI)
NCT06669273Suspected Prostate Cancer (increased PSA Level)
University Hospital, Clermont-Ferrand
Not applicable
70
Clermont-Ferrand
2024-10
Not yet open
Home-based Nurse Intervention in the Care of High Risk of Death Patients After Discharge From Geriatric Department
NCT06481917Health Services for the Aged, Advance Care Planning
Lille Catholic University
Not applicable
104
Amiens, Caen, Lille, Lomme, Rouen
2024-10
Not yet open
The Effect of Mucogyne® Ovule on Wound Healing (ORIGYNE)
NCT06585579Cervicovaginitis
Biocodex
Not applicable
144
Amiens, Besançon, Trévenans
2024-10
Recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
NCT05663515Pancreatic Cancer
DrugExenatide
AstraZeneca
Observational
24,000
Paris
2024-09-30
Recruiting
Effect of Genicular Arteries Embolization in Symptomatic Knee Osteoarthritis LipioJoint-2
NCT06497140Knee Osteoarthritis
Assistance Publique - Hôpitaux de Paris
Phase 3
130
Paris
2024-09-30
Active, closed
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.
NCT06473779Severe Asthma
AstraZeneca
Phase 3
326
Créteil, La Tronche, Lyon, Marseille, Montpellier, Strasbourg
2024-09-30
By invitation
Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients
NCT06657859Pmm2-CDG, Phosphomannomutase 2 Deficiency
Glycomine, Inc.
Phase 2
90
Paris
2024-09-30
Recruiting
Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma
NCT06813573Follicular Lymphoma, Diffuse Large B-Cell Lymphoma
DrugBlood sampling
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
50
Villejuif
2024-09-30
Recruiting
Identification of Early Markers for ALS
NCT07213440Amyotrophic Lateral Sclerosis (ALS)
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
60
Tours
2024-09-30
Recruiting
Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department
NCT07312461Macroscopic Hematuria
University Hospital, Strasbourg, France
Observational
100
Strasbourg
2024-09-30
Not yet open
PAthwAy of Dyspneic patIent in Emergency in France
NCT06509854Acute Dyspnea
Pr. Nicolas GIRERD
Observational
89,700
Besançon, Dijon, Lyon, Nancy
2024-09-30
Recruiting
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.
NCT06479070SCC - Squamous Cell Carcinoma, Upper Aero-digestive Tract (UADT) Neoplasm
Institut de Cancérologie de Lorraine
Not applicable
188
Caen, Vandœuvre-lès-Nancy, Besançon, Dijon, Reims, Strasbourg
2024-09-30
Recruiting
R-GASTIM- Study of Gastric Cancer Operable
NCT07787052Gastric Cancers
Centre Leon Berard
Observational
60
Lyon
2024-09-30
Recruiting
Description of the Immune Response to Yellow Fever Vaccination
NCT06718127Immunization, Infections
DrugBlood samples collection
Institut Pasteur
Not applicable
38
Paris
2024-09-30
Recruiting
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
NCT06551142Neoplasms
DrugsRis-Rez·Tarlatamab·Dostarlimab·Cetuximab
GlaxoSmithKline
Phase 1
845
Bordeaux, Lyon, Villejuif
2024-09-30
Recruiting
Dexamethasone and Pregnancy: Maternal Effects
NCT06259994Dexamethasone During Pregnancy
Assistance Publique - Hôpitaux de Paris
Observational
35
Bordeaux, Bron, Grenoble, Le Kremlin-Bicêtre, Lille, Nantes, Paris, Toulouse
2024-09-30
Recruiting
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NCT05486884Cardiac Arrest, Out-of-hospital Cardiac Arrest (OHCA)
Centre Hospitalier le Mans
Not applicable
1,380
Montpellier, Brest, Brive-la-Gaillarde, Caen, Cannes, Cholet, Dieppe, Dijon
2024-09-28
Recruiting
RAT-HEMATO : Return to Work After Malignant Hemopathy
NCT06262789Leukemia, Lymphoma, Multiple Myeloma
University Hospital, Angers
Not applicable
264
Angers, Brest, Caen, Cholet, Montivilliers, Morlaix, Rennes, Rouen
2024-09-27
Recruiting
First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors
NCT06622486Solid Tumor, Adult
Egle Therapeutics
Phase 1/2
50
Dijon, Montpellier, Paris
2024-09-27
Recruiting
Comparison of the Effectiveness of an Adapted Physical Activity Program in a Dedicated Structure to a Self-program in Patients in Chronic Phase of a Stroke
NCT06061770Stroke
Assistance Publique Hopitaux De Marseille
Not applicable
40
Marseille
2024-09-27
Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
NCT06613698Liver Diseases, Alcoholic
DrugGSK4532990
GlaxoSmithKline
Phase 2
393
Angers, Bobigny, Créteil, Lille, Montpellier, Rouen
2024-09-27
Rows per page Showing 4301–4400 of 9693
Previous 42 43 44 45 46 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-france?page=44

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,693 studies in total at the last sync on 26 Sep 2026, 19:56 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in France?

6,031 of the 9,693 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:56 UTC sync. A further 1,335 have not yet opened recruitment, 2,202 are active but closed to new participants, and 125 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (143) Multiple Myeloma (88) Cancer (81) Stroke (75) Multiple Sclerosis (60) Heart Failure (56) Prostate Cancer (56) Obesity (54) Non-Small Cell Lung Cancer (50) Acute Myeloid Leukemia (48) Alzheimer Disease (47) Ovarian Cancer (45) Ulcerative Colitis (42) Carcinoma, Non-Small-Cell Lung (41) Atrial Fibrillation (41)
→

Browse trials by site location

Paris (2816) Lyon (1391) Bordeaux (1387) Marseille (1292) Lille (1277) Montpellier (1016) Toulouse (1001) Nantes (902) Dijon (816) Angers (771) Nice (763) Clermont-Ferrand (754) Brest (728) Caen (720) Strasbourg (653)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.